We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
KSD is a costly disease, comparable to the combined cost of prostate and bladder cancer in UK.
No takes yet. Share an insight, caveat, or question.
Geraghty et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: